Malaysia and Zetrix AI Partner to Build Global Standards for Shariah-Compliant...
JOHOR BAHRU, Malaysia, Sept. 13, 2025 /PRNewswire/ -- In a significant step towards islamic values-based artificial intelligence, Zetrix AI Berhad, developer of the world's first Shariah-aligned Large Language Model (LLM) NurAi and the Government of Malaysia, through the Prime Minister's Department (Religious Affairs), today signed a Letter of Intent (LOI)...
Desay SV Shines at IAA Mobility with “In Europe, with Europe,...
MUNICH, Sept. 14, 2025 /PRNewswire/ -- During Sept. 8-12, 2025, Desay SV, a leading automotive intelligence product supplier, made a notable appearance at IAA Mobility, presenting the regional concept of "In Europe, with Europe, for All". This concept reflects the company's determination to integrate into the European market, collaborate...
NurExone Biologic Announces Corporate Updates including Israel Patent Grant and Private...
TORONTO and HAIFA, Israel, Sept. 11, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a pioneering biopharmaceutical company developing exosome-based regenerative therapies, is pleased to provide the following corporate updates. Israeli Patent Grant Expands Global...
Data published in The New England Journal of Medicine demonstrate RYBREVANT®▼(amivantamab)...
Chemotherapy-free combination regimen has the potential to usher in new era for first-line treatment, with median overall survival projected to exceed four years, surpassing monotherapy TKI osimertinib by more than one year*1 BEERSE, BELGIUM, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Janssen-Cilag International NV, a Johnson &...
